Proposal to widen access to brentuximab vedotin for systemic anaplastic large cell lymphoma

We are seeking feedback on a proposal to widen access to brentuximab vedotin for systemic anaplastic large cell lymphoma, to improve the lives of around twelve people in New Zealand in the first year of funding.

Please follow this link to the consultation.

We welcome your feedback on this proposal at consult@pharmac.govt.nz. 

Consultation is open until 5pm Thursday 19 February 2026.  If there are people, you think would be interested in providing feedback to this consultation, please share this.

Ngā mihi

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz